The document discusses severe combined immunodeficiency (SCID) caused by adenosine deaminase (ADA) deficiency. It notes that ADA deficiency accounts for 20% of SCID cases and is the most severe form, affecting both cell-mediated and humoral immunity. Without treatment, ADA-deficient individuals die from infections within the first year of life. The most successful treatments are bone marrow transplantation or enzyme replacement therapy with polyethylene glycol-modified bovine ADA.
Presentation given by Dr. Karthikeyan at Department of Biochemistry, Maulana Azad Medical College.
Addition:
There are certain proteins which are degraded by proteasome without ubiquitin tag. one such example is ornithine decarboxylase - rate limiting enzyme of polyamine synthesis.
Introduction, causes and symptoms, Mechanism and treatment are been explained about this deadly disease SCID where production of T and B cells is affected.
Presentation given by Dr. Karthikeyan at Department of Biochemistry, Maulana Azad Medical College.
Addition:
There are certain proteins which are degraded by proteasome without ubiquitin tag. one such example is ornithine decarboxylase - rate limiting enzyme of polyamine synthesis.
Introduction, causes and symptoms, Mechanism and treatment are been explained about this deadly disease SCID where production of T and B cells is affected.
The gal operon is a prokaryotic operon, which encodes enzymes necessary for galactose metabolism. The operon contains two operators, OE and OI. The former is just before the promoter, and the latter is just after the galE gene.This slide share includes some of the reasearch done on the galactose operons explained with review articles
The gal operon is a prokaryotic operon, which encodes enzymes necessary for galactose metabolism. The operon contains two operators, OE and OI. The former is just before the promoter, and the latter is just after the galE gene.This slide share includes some of the reasearch done on the galactose operons explained with review articles
explains the breakdown of purine. source and excretion of purine is explained. hyperuricemia and hypouricemia is discussed. types of Gout, clinical features and treatment is included.
Nanobiotechnological applications in dna therapySenthil Natesan
Gene therapy is a form of molecular medicine that has the potential to influence significantly human health in this 21st century. It promises to provide new treatments for a large number of inherited and acquired diseases (Verma and Weitzman, 2005). The basic concept of gene therapy is simple which includes introduction of a piece of genetic material into target cells that will result in either a cure for the disease or a slowdown in the progression of the disease. To achieve this goal, gene therapy requires technologies capable of gene transfer into a wide variety of cells, tissues, and organs. A key factor in the success of gene therapy is the development of delivery systems that are capable of efficient gene transfer in a variety of tissues, without causing any associated pathogenic effects. Vectors based upon many different viral systems, including retroviruses, lentiviruses, adenoviruses, and adeno-associated viruses, currently offer the best choice for efficient gene delivery.
Congenital hypothyroidism is quite common in Indians and is the most common reversible congenital cause of mental retardation.
Early identification and intervention is important as Thyroid dependent brain development is complete by 3 years of age.
Universal screening is ideal as most cases are sporadic.
Positive cases on screening by filter paper test should be confirmed by serum levels estimation.
Serum Thyroid hormone levels are of primary importance in diagnosing and managing this condition, other investigations are ancillary.
Age based reference values must be followed in interpreting the results.
Timely monitoring (serum hormone levels, compliance, growth & development) and adequate counseling of care givers are key in managing this condition.
Discovered by Eloise Giblett in 1972.
ADA deficiency or ADA-SCID or Bubble boy disorder.
Recognized as the first immunodeficiency disorder.
Accounts for 10-15% of all cases of SCID.
An autosomal recessive metabolic disorder causes immunodeficiency.
Rare occurring disease.
Both males and females are equally affected.
All racial and ethnic groups are affected
This is a journal club presentation where we present good quality papers from leading journals of the world. This particular paper deals with new biomarkers for Rheumatoid Arthritis.
Peptide nucleic acid (PNA) is a synthetic analogue of nucleic acids (DNA & RNA) with unique characteristics and several potential applications in biotechnology and biomedicine. This presentation is a slide format of an 2020 review article from Yale university scientists focused on genome editing application of PNA in votro, ex vivo and in vivo.
Multi-source connectivity as the driver of solar wind variability in the heli...Sérgio Sacani
The ambient solar wind that flls the heliosphere originates from multiple
sources in the solar corona and is highly structured. It is often described
as high-speed, relatively homogeneous, plasma streams from coronal
holes and slow-speed, highly variable, streams whose source regions are
under debate. A key goal of ESA/NASA’s Solar Orbiter mission is to identify
solar wind sources and understand what drives the complexity seen in the
heliosphere. By combining magnetic feld modelling and spectroscopic
techniques with high-resolution observations and measurements, we show
that the solar wind variability detected in situ by Solar Orbiter in March
2022 is driven by spatio-temporal changes in the magnetic connectivity to
multiple sources in the solar atmosphere. The magnetic feld footpoints
connected to the spacecraft moved from the boundaries of a coronal hole
to one active region (12961) and then across to another region (12957). This
is refected in the in situ measurements, which show the transition from fast
to highly Alfvénic then to slow solar wind that is disrupted by the arrival of
a coronal mass ejection. Our results describe solar wind variability at 0.5 au
but are applicable to near-Earth observatories.
Richard's entangled aventures in wonderlandRichard Gill
Since the loophole-free Bell experiments of 2020 and the Nobel prizes in physics of 2022, critics of Bell's work have retreated to the fortress of super-determinism. Now, super-determinism is a derogatory word - it just means "determinism". Palmer, Hance and Hossenfelder argue that quantum mechanics and determinism are not incompatible, using a sophisticated mathematical construction based on a subtle thinning of allowed states and measurements in quantum mechanics, such that what is left appears to make Bell's argument fail, without altering the empirical predictions of quantum mechanics. I think however that it is a smoke screen, and the slogan "lost in math" comes to my mind. I will discuss some other recent disproofs of Bell's theorem using the language of causality based on causal graphs. Causal thinking is also central to law and justice. I will mention surprising connections to my work on serial killer nurse cases, in particular the Dutch case of Lucia de Berk and the current UK case of Lucy Letby.
Slide 1: Title Slide
Extrachromosomal Inheritance
Slide 2: Introduction to Extrachromosomal Inheritance
Definition: Extrachromosomal inheritance refers to the transmission of genetic material that is not found within the nucleus.
Key Components: Involves genes located in mitochondria, chloroplasts, and plasmids.
Slide 3: Mitochondrial Inheritance
Mitochondria: Organelles responsible for energy production.
Mitochondrial DNA (mtDNA): Circular DNA molecule found in mitochondria.
Inheritance Pattern: Maternally inherited, meaning it is passed from mothers to all their offspring.
Diseases: Examples include Leber’s hereditary optic neuropathy (LHON) and mitochondrial myopathy.
Slide 4: Chloroplast Inheritance
Chloroplasts: Organelles responsible for photosynthesis in plants.
Chloroplast DNA (cpDNA): Circular DNA molecule found in chloroplasts.
Inheritance Pattern: Often maternally inherited in most plants, but can vary in some species.
Examples: Variegation in plants, where leaf color patterns are determined by chloroplast DNA.
Slide 5: Plasmid Inheritance
Plasmids: Small, circular DNA molecules found in bacteria and some eukaryotes.
Features: Can carry antibiotic resistance genes and can be transferred between cells through processes like conjugation.
Significance: Important in biotechnology for gene cloning and genetic engineering.
Slide 6: Mechanisms of Extrachromosomal Inheritance
Non-Mendelian Patterns: Do not follow Mendel’s laws of inheritance.
Cytoplasmic Segregation: During cell division, organelles like mitochondria and chloroplasts are randomly distributed to daughter cells.
Heteroplasmy: Presence of more than one type of organellar genome within a cell, leading to variation in expression.
Slide 7: Examples of Extrachromosomal Inheritance
Four O’clock Plant (Mirabilis jalapa): Shows variegated leaves due to different cpDNA in leaf cells.
Petite Mutants in Yeast: Result from mutations in mitochondrial DNA affecting respiration.
Slide 8: Importance of Extrachromosomal Inheritance
Evolution: Provides insight into the evolution of eukaryotic cells.
Medicine: Understanding mitochondrial inheritance helps in diagnosing and treating mitochondrial diseases.
Agriculture: Chloroplast inheritance can be used in plant breeding and genetic modification.
Slide 9: Recent Research and Advances
Gene Editing: Techniques like CRISPR-Cas9 are being used to edit mitochondrial and chloroplast DNA.
Therapies: Development of mitochondrial replacement therapy (MRT) for preventing mitochondrial diseases.
Slide 10: Conclusion
Summary: Extrachromosomal inheritance involves the transmission of genetic material outside the nucleus and plays a crucial role in genetics, medicine, and biotechnology.
Future Directions: Continued research and technological advancements hold promise for new treatments and applications.
Slide 11: Questions and Discussion
Invite Audience: Open the floor for any questions or further discussion on the topic.
This pdf is about the Schizophrenia.
For more details visit on YouTube; @SELF-EXPLANATORY;
https://www.youtube.com/channel/UCAiarMZDNhe1A3Rnpr_WkzA/videos
Thanks...!
The increased availability of biomedical data, particularly in the public domain, offers the opportunity to better understand human health and to develop effective therapeutics for a wide range of unmet medical needs. However, data scientists remain stymied by the fact that data remain hard to find and to productively reuse because data and their metadata i) are wholly inaccessible, ii) are in non-standard or incompatible representations, iii) do not conform to community standards, and iv) have unclear or highly restricted terms and conditions that preclude legitimate reuse. These limitations require a rethink on data can be made machine and AI-ready - the key motivation behind the FAIR Guiding Principles. Concurrently, while recent efforts have explored the use of deep learning to fuse disparate data into predictive models for a wide range of biomedical applications, these models often fail even when the correct answer is already known, and fail to explain individual predictions in terms that data scientists can appreciate. These limitations suggest that new methods to produce practical artificial intelligence are still needed.
In this talk, I will discuss our work in (1) building an integrative knowledge infrastructure to prepare FAIR and "AI-ready" data and services along with (2) neurosymbolic AI methods to improve the quality of predictions and to generate plausible explanations. Attention is given to standards, platforms, and methods to wrangle knowledge into simple, but effective semantic and latent representations, and to make these available into standards-compliant and discoverable interfaces that can be used in model building, validation, and explanation. Our work, and those of others in the field, creates a baseline for building trustworthy and easy to deploy AI models in biomedicine.
Bio
Dr. Michel Dumontier is the Distinguished Professor of Data Science at Maastricht University, founder and executive director of the Institute of Data Science, and co-founder of the FAIR (Findable, Accessible, Interoperable and Reusable) data principles. His research explores socio-technological approaches for responsible discovery science, which includes collaborative multi-modal knowledge graphs, privacy-preserving distributed data mining, and AI methods for drug discovery and personalized medicine. His work is supported through the Dutch National Research Agenda, the Netherlands Organisation for Scientific Research, Horizon Europe, the European Open Science Cloud, the US National Institutes of Health, and a Marie-Curie Innovative Training Network. He is the editor-in-chief for the journal Data Science and is internationally recognized for his contributions in bioinformatics, biomedical informatics, and semantic technologies including ontologies and linked data.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.Sérgio Sacani
The return of a sample of near-surface atmosphere from Mars would facilitate answers to several first-order science questions surrounding the formation and evolution of the planet. One of the important aspects of terrestrial planet formation in general is the role that primary atmospheres played in influencing the chemistry and structure of the planets and their antecedents. Studies of the martian atmosphere can be used to investigate the role of a primary atmosphere in its history. Atmosphere samples would also inform our understanding of the near-surface chemistry of the planet, and ultimately the prospects for life. High-precision isotopic analyses of constituent gases are needed to address these questions, requiring that the analyses are made on returned samples rather than in situ.
Professional air quality monitoring systems provide immediate, on-site data for analysis, compliance, and decision-making.
Monitor common gases, weather parameters, particulates.
7. SCID is a group of inherited disorders that
drastically compromises innate and
adaptive immune responses.
disruption in the development of T cells.
lack of B cell function.
Without treatment, opportunistic
infections eventually cause death.
Although there are 10 different types
that we know of, the two most common
are X-linked Severe Combined
Immunodeficiency (XSCID) and Adenosine
deaminase deficiency (ADA) SCID.
SCID is estimated to occur in 100,000 to
500,000 births per year (Fischer, 2000). Retrieved from:
http://bio116.pbworks.com/f/1245522611/1245522611/chr2
1-22-X-Ysm.gif
8. ADA mutations give rise to ADA SCID.
A defective ADA protein will not be able to effectively detoxify metabolic products (e.g.
ATP, S-adenosyl homocysteine) of the purine salvage pathway. Thus, lymphocytes undergo
apoptosis (Kalman et al., 2004). This has an earlier onset than the other forms.
IL-2RG mutations are associated with XSCID. A defective IL-2RG prevents activation of B
cells by Helper T cells (TH1). These mutations disrupt the gamma chain protein, which is a
common subunit for receptors for IL2, 4, 7, 9, and 15 (Cavazzana-Calvo, 2000).
These help differentiation of T cells, B cells and NK cells.
Type of gene Abnormal
genes in SCID
patients
Cytokine-receptor
genes
IL-2RG, JAK3,
IL-7Rα
Antigen-receptor
genes
RAG1, RAG2,
Artemis,
CD3δ, CD3ε
Other genes ADA, CD45
Buckley, 2004
9.
10. SCID-Severe Combined Immunodeficiency Syndrome
AMP
Adenosine
Inosine
H20
Pi
H20
NH3
Hypoxanthine
Nucleotidase
Adenosine deaminase*
ADA catalyzes the irreversible
deamination of adenosine to form
inosine, and of deoxyadenosine to
deoxyinosine.
11. N
N N
N
Ribose-P
NH2
N
N N
N
Ribose-P
OH
H2O NH3
AMP deaminase
N
N N
N
Ribose
NH2
Nucleotidase
H2O
Pi
HN
N N
N
Ribose
O
Adenosine deaminase
H2O NH3
Nucleotidase
H2O
Pi
Purine nucleoside
phosphorylase
HN
N N
N
H
O
may be reused
through
salvage pathway
Pi
Ribose-1-P
hypoxanthine
Degradation
of AMP
12. Diagnosis is usually made at 6 months of age (Kalman et al., 2004).
Before this time, newborns are relatively protected by the mother’s antibodies
in the colostrum.
Frequent infections in babies include oral candidiasis (thrush) and persistent
diarrhea. Growth impairment and/or interstitial pneumonitis can also occur
(Fischer, 2000).
They do not respond to usual therapy.
SCID patients have recurrent viral, fungal, and bacterial infections that usually
occur in the respiratory tract and gut (Fischer, 2000).
SCID patients often do not respond to the antibiotics used to treat bacterial
infections.
Oral candidiasisPneumonia
Diffuse rash in an
infant with ADA
deficiency.
13. clinical symptoms
early in life
chronic diarrhea, failure to thrive
graft versus host disease (on skin)
complications after vaccination with live
vaccines
unusual infections, severe course
family history
14.
15. Adenosine deaminase (ADA) is an essential enzyme of
purine metabolism and is highly conserved throughout
phylogeny.
investigations indicated that ADA deficiency accounts for
approximately 20% of cases of human SCID and that it is
the most severe of the immunodeficiency diseases,
affecting both cell-mediated and humoral immunity
(Buckley et al., 1997; Hershfield and Mitchell, 2001).
Soon after their discovery that defects in ADA were
associated with immunodeficiency, Giblett and colleagues
examined other immunodeficient individuals for
deficiencies in purine catabolic enzymes and found that
defects in purine nucleoside phosphorylase also result in
immunodeficiency disease.
16.
17. molecular weight of 41 kDa .
adenosine aminohydrolase, EC 3.5.4.4
monomeric, zinc-dependent enzyme.
encoded by 12 exons.
ADA gene is 32 kb.
The gene is on chromosome 20q13.11.
mostly an intracellular enzyme.
found throughout body.
part of the purine catabolism pathway.
most active in lymphocytes.
functions in eliminating adenosine and deoxyadenosine.
(Garrett and Grisham 2010; Genetic Science Learning Center 2008;
Genetics Home Reference 2009; Hershfield 1998)
18. Associated with the loss of ADA activity ,The thymus is absent or small and
dysplastic in ADA-deficient individuals (Borzy et al., 1979).
They have severely reduced numbers of peripheral T, B, and natural killer
(NK) cells(Buckley et al., 1997).
ADA-deficient SCID is the only immunodeficiency in which all three cell
types are severely reduced in number.
Autosomal recessive disease .
In the absence of ADA lymphocytes are destroyed.
19. Deoxyadenosine and deoxyguanosine are toxic to human lymphoid cells
in culture and have been implicated in the pathogenesis of the
immunodeficiency states associated with adenosine deaminase and
purine nucleoside phosphorylase deficiency, respectively.
deoxyadenosine is not destroyed, is converted to dAMP and then into
dATP.
There marked increase in cellular concentrations of dATP due to the lack
of conversion of excess deoxyadenosine to deoxyinosine and
hypoxanthine .
dATP is a potent feedback inhibitor of deoxynucleotide biosynthesis and
DNA replication
20. Lymphopenia
Defect in T-cell activation
e.g. in vitro PHA
low serumimmunoglobulins
beware – antibody transferred
from mother
Elevated IgE
Peripheral eosinophilia
Elevated plasma adenosine
Elevated plasma and urine 2-
deoxyadenosine levels
Elevated dATP levels in erythrocytes.
21. Total lymphocyte counts are taken.
For more reliable results, flow cytometry is used to enumerate T, B,
and NK cells. Lymphocyte function is also tested by analyzing in vitro
responses of lymphocytes to common antigens (Kalman et al., 2004).
ADA enzyme activity can be measured as well (Kalman et al., 2004).
Diagnosis can be confirmed by DNA-sequence analysis, or protein
analysis (Kalman et al., 2004). This is important for carriers of XSCID.
(Kalman et
al., 2004)
22. Prenatal: DNA-sequence analysis, ADA enzyme levels in umbilical-cord
blood (Kalman et al., 2004).
Prenatal diagnosis has been accomplished by assay of the enzyme in
cultured amniocytes and chorionic villus Samples.
ADA is markedly reduced or undetectable in affected patients
(homozygotes), and approximately one-half normal levels are found in
individuals heterozygous for ADA deficiency.
23. A considerable number of mutations have been
identified, most of them single amino acid changes.
A 329V, a relatively common mutation, has been
found in a number of unrelated patients so has
R211H.
24. Purine nucleoside phosphorylase (PNP) deficiency has been associated with T-
lymphocyte dysfunction in some patients .
The mechanism(s) whereby these enzyme deficiency states affect lymphocyte
development and/or function has not been fully elucidated.
Whereas ADA deficiency results in combined bone marrow-derived (B)- and
thymus derived (T)-lymphocyte deficiency , PNP-deficient patients exhibit T-
cell dysfunction with normal B lymphocyte function.
25. While there are a number of proposed mechanisms to
explain the association of lymphotoxicity with ADA
deficiency The cause of the T-cell deficiency associated
with the absenice of PNP activity has received less
attention.
It was postulated that an accumulation of the PNP
substrate, inosine, inhibited ADA activity causing
finentional ADA deficiency.
26. Purine nucleoside phosphorylase (PNP, EC 2.4.2.1) deficiency causes a
clinical syndrome of SCID indistinguishable from that of ADA defciency.
It was also discovered by Giblett and colleagues .
PNP catalyzes the reversible cleavage of inosine and guanosine to their
respective bases hypoxanthine and guanine.
Deoxyinosine and deoxyguanosine are also substrates.
27. PNP deficiency is unique among immunodeficiency diseases,
because it presents with hypouricemia and urinary excretion
of uric acid is reduced.
Deficiency of enzymatic activity can be demonstrated in
erythrocyte lysates or cultured lymphroblasts.
Prenatal diagnosis may be made by assay of cultured
amniocytes or chorionic villus cells.
Heterozygotes may have intermediate levels of activity.
28.
29. Immunodeficiency is the most thoroughly studied
feature of human ADA deficiency; however, other
abnormalities have been reported :
1. Liver abnormalities
2. Neurological abnormalities
3. Pulmonary insufficiencies of unknown etiology
4. Renal abnormalities
30. Ectoenzymes are membrane proteins that have their enzymatically active
site outside the plasma membrane, in the extracellular environment.
Many ectoenzymes are type II integral membrane proteins with a short
amino terminus in the cytosol or are glycosylphosphatidylinositol-linked
molecules. Many ectoenzymes (such as CD26, CD38, CD73, autotaxin
and vascular adhesion protein 1) are also found as soluble forms in
biological fluids
31. Early evidence from work in brain synaptosomes suggested
that the enzyme could be an ectoenzyme.
In lymphoid cells, ectoenzymatic activity of ADA1 was also
found.
The obvious role of this enzyme located on the cell surface
of lymphocytes and monocytes was to deaminate
adenosine, making it less available for uptaking and
metabolism, and also for adenosine-receptor activation.
32. Cell surface ADA1-binding proteins have been identified.
Interestingly, the interaction of ADA1 with these anchoring proteins leads
to costimulation of T-cell activation.
Recent studies performed with professional antigen-presenting cells and
T lymphocytes have shown that ADA1 can bridge the two cell types
together by a cross-linking established between different anchoring
molecules in each cell.
Some aspects of ADA action are similar to that of growth factors.
In fact, ADA1 is a member of the adenosine deaminase growth factor
(ADGF) family.
Some molecular mechanisms that occur in ADA-related SCID and the role
ADA1 may play in acquired immunodeficiency are also reviewed here.
33. T cell depletion in ADA SCID may be at least partially due to
blocks in TCR-driven thymocyte maturation by adenosine, as well
as to direct apoptotic effects of intracellular adenosine, 2′-
deoxyadenosine.
and dATP propose that there may be at least two alternative or
simultaneously operating mechanisms of T cell depletion:
(a) intracellular lymphotoxicity of intracellularly accumulated
adenosine, 2′-deoxyadenosine, and dATP.
(b) inhibition of TCR signaling and, hence, the inhibition/block of
TCR-driven processes ofT cell selection.
34. A smaller population of ADA-deficient patients
presents later in life with a less severe form of
immunodeficiency that coincides with less
severe loss of ADA enzymatic activity and
associated metabolic disturbances (Santisteban
et al., 1993).
Without intervention, ADA-deficient
individuals die from overwhelming
infections within the first year of life.
35. The most successful treatment for ADA deficiency is
histocompatible bone marrow transplantation from an HLA-
matched sibling.
Because this treatment option is seldom available, alternative
treatments have been identified, including T cell–depleted
haploidentical bone marrow transplantation from a parent.
However, these approaches have met with limited success.
36. A successful biochemical approach for the treatment
of ADA deficiency involves the use of enzyme
replacement therapy wherein a polyethylene glycol–
modified form of bovine ADA (PEG–ADA) is provided to
patients by twice weekly intramuscular injection
(Hershfield et al., 1993).
37.
38.
39. Polyethylene glycol appears to protect the bovine ADA
from proteolytic and immunologic attack, hence
increasing the circulating half-life of this exogenous
enzyme.
ADA replacement therapy is effective in reducing the
metabolic impact of ADA deficiency and has prolonged the
life of individuals who have in some cases been treated for
more than 8 years (Hershfield, 1995).
40. Relatively few complications have been reported
with respect to allergic reactions or
immunogenicity to PEG–ADA.
it appears to be the best option for the prolonged
treatment of ADA-deficient patients who lack
HLA-identical marrow donor.
41. gene therapy
the hope is that efficient transfer of a recombinant ADA
gene into hematopoietic cells will result in the outgrowth
of a genetically repaired immune system.
For these and other reasons, ADA gene therapy studies
were the first to use ex vivo approaches to stably
introduce new genetic information into patients.